NCT03827382

Brief Summary

The aim of the study is to test the efficacy, feasibility, and safety of a bicycle exercise followed by an intensive lifestyle intervention for 3 months in patients with recent onset and medically untreated type 2 diabetes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 1, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

6.9 years

First QC Date

December 6, 2018

Last Update Submit

February 11, 2025

Conditions

Keywords

Life Style InterventionType 2 Diabetes mellitus

Outcome Measures

Primary Outcomes (1)

  • metabolic control

    fasting glucose \< 7.6 mM and HbA1c below a target stratified for three groups according to HbA1c at baseline.

    3 months

Secondary Outcomes (25)

  • Absolute HbA1c reduction per stratification group

    3 months

  • Absolute HbA1c reduction per stratification group

    6 months

  • Proportion of patients achieving HbA1c target in each stratification group

    3 months

  • Feasibility of bicycle exercise at study enrollment in the ER

    2 hours

  • Proportion of patients achieving HbA1c target in each stratification group

    6 months

  • +20 more secondary outcomes

Study Arms (2)

Intervention

ACTIVE COMPARATOR

Patients with intensive Lifestyle intervention

Behavioral: Lifestyle Intervention

Control

NO INTERVENTION

Patients with Standard Diabetes care

Interventions

Physical activity program: 3-5 aerobic training sessions (15-40 minutes each) per week, combined with 2 resistance training per week as well as motivational coaching via telephone Nutritional counseling

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent as documented by signature
  • Type 2 diabetes diagnosed within the last two years according to the American Diabetes Association (ADA) criteria
  • Age ≥ 18 years
  • HbA1c ≥ 7.5 %

You may not qualify if:

  • Clinically instable patient as defined by the physicians on duty including signs of new cardiac ischemia in the ECG, systolic blood pressure ≥ 200 mmHg, fever ≥ 38.5 °C, symptoms of SIRS or reduced vigilance.
  • Anti-diabetic medication for ≥ 24 hours
  • Inability to perform a bicycle exercise during 30 minutes
  • Previous lifestyle-intervention by an endocrinologist
  • Engagement in physical activity more than five times per week
  • Enrollment in other interventional study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Basel

Basel, Canton of Basel-City, 4031, Switzerland

RECRUITING

Cantonal Hospital Olten

Olten, Canton of Solothurn, 4600, Switzerland

RECRUITING

Hopital du Jura

Delémont, 2800, Switzerland

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Marc Y Donath, Prof.

    University Hospital, Basel, Switzerland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marc Y Donath, Prof.

CONTACT

Matthias Hepprich, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2018

First Posted

February 1, 2019

Study Start

February 1, 2019

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations